Navigation Links
New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
Date:10/24/2007

k at least one dose of treatment, found that treatment-emergent adverse events were reported in approximately 63% of AMBIEN CR-treated patients compared to 50% of patients treated with placebo. Serious adverse events were reported in approximately 3% of study patients taking AMBIEN CR compared to approximately 2% of patients treated with placebo. These adverse events were not considered by the investigator to be related to the study treatment.

About Insomnia

Insomnia can be a serious medical condition characterized by difficulty falling asleep, waking up often during the night and having trouble going back to sleep, waking up too early in the morning and feeling tired upon waking. More than 30 million Americans are affected by chronic insomnia each year.

Patients with chronic insomnia report higher rates of absenteeism and demonstrate poor work efficiency compared to normal sleepers. Chronic and occasional insomniacs were both more likely to doze off during daytime activities or when bored, and to take naps than individuals who do not experience insomnia. Insomnia can lead to stress and reduced productivity, and thus may be costly to the workplace.

About AMBIEN CR

AMBIEN CR is the first and only dual-layer, extended-release prescription sleep medication indicated to help induce and maintain sleep with no significant decrease in next-day performance. AMBIEN CR is delivered in two stages. The first layer dissolves quickly to induce sleep. The second layer is released more gradually into the body to help provide more continuous sleep.

Important Safety Information

AMBIEN CR is a treatment option you and your healthcare provider can consider along with lifestyle changes and can be taken for as long as your provider recommends. Until you know how AMBIEN CR will affect you, you shouldn't drive or operate machinery. Be sure you're able to devote 7 to 8 hours to sleep before being active again. Sleepwalking, and eating or driving whi
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
4. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... A new application developed ... clinical review of specialty pharmaceuticals has increased health ... reviewed while reducing costs. ,, AIM, a leading ... health plan clients representing over 35 million consumers ... WLP ), adapted the successful clinical ...
(Date:12/16/2009)... 16 AVAX Technologies, Inc. (Pink Sheets: ... it recently closed a bridge loan financing (the ... Warrant Purchase Agreement (the "Agreement") with Firebird Global ... the Company sold a convertible promissory note, due ... of US$1,400,000, and issued a warrant to purchase ...
(Date:12/16/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... elected Nelda Connors as a Director. ,, ... Metal Products division of Tyco International. Previously, she ... positions in operations and general management. Prior to ... executive and management capacities with Ford, Chrysler and Mogami ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 1Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 4Saint Louis Public School District Awards Contract to Accelify 58302 1Saint Louis Public School District Awards Contract to Accelify 58302 2Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure 58297 1Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure 58297 2
... 9 Sequoia Pharmaceuticals presented,positive results today ... volunteers and,preclinical studies on SPI-452, a novel ... Pharmacokinetic enhancers increase drug levels of,co-administered agents ... These increased drug levels can lead to ...
... The U.S. Agency for International Development (USAID) ... who are in the midst of an expanding humanitarian ... epidemic have left the people of Zimbabwe in danger ... Malaria Initiative, is supporting emergency Indoor Residual Spraying (IRS) ...
Other Medicine Technology:Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 2Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 3Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 4Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 5USAID Provides Malaria Assistance to Zimbabwe 2
(Date:12/16/2009)... New Enterprise Associates, Inc. (NEA), a leading global ... its portfolio companies, Acclarent, Inc., has entered into ... Inc., a Johnson & Johnson company, in an ... estimated cash on hand at time of closing). ... and commercializing devices that address conditions affecting the ...
(Date:12/16/2009)... Blacks, other minorities might not gain full benefit from ... -- Human embryonic stem cell lines currently used for ... finds. , That could mean that non-whites will ... that research down the line, experts say. , Blacks ... most widely used stem cell lines studied showed any ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 Losing has never felt ... knows maintaining his healthy new lifestyle means continuing to ... Drinking fat free milk is one healthy choice that ... a simple step everyone can take. Every glass of ... muscle, potassium to help maintain normal blood pressure, and ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at ... holidays can be a particularly difficult time. Wounded ... than ever on the healing power of connecting with ... got easier for Walter Reed patients as Verizon Wireless ... hundreds of minutes of holiday talk time for 2,500 ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 As a result of ... a new peer reviewed cancer research program is included ... ,, This new cancer research program will research ... the breast, prostate, lung and ovarian cancer research programs ... Command. ,, The $15 million in funding ...
Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3
... patients with chronic obstructive pulmonary disease (COPD) improves exercise ... unless they have resting hypoxemia, according to researchers in ... prescribed for those who do not meet criteria for ... of Medicine and Physical Therapy at West Park Healthcare ...
... pregnancy and breastfeeding may be putting their children at ... study funded by the Wellcome Trust and carried out ... that pregnant and breastfeeding women should not indulge in ... that they are "eating for two". , The study(1), ...
... is greater among kidney transplant patients and people with ... suggests the disease is associated with immune deficiency. ... South Wales in Sydney and colleagues compared the incidence ... with that of kidney transplant patients, who have suppressed ...
... measure apolipoprotein (apo) B: apo A-I ratio is not ... traditional lipid ratios that include total cholesterol and HDL-C, ... of JAMA. , Current risk-prediction instruments and guidelines for ... low-density lipoprotein cholesterol (LDL-C), total cholesterol, or both for ...
... can improve their understanding of the potential increased risk ... recent study conducted by researchers from The Childrens Hospital ... in New Haven, CT. , Like many radiology departments ... radiation exposure to children caused by increased usage of ...
Frederic Geissmann and colleagues find that Langerhans cell accumulation in Langerhans cell histiocytosis results from survival rather than uncontrolled proliferation, and is associated with the expan...
Other Medicine News:Health News:Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia 2Health News:Eating junk food whilst pregnant and breastfeeding may lead to obese offspring 2Health News:Use of certain lipid measures not more effective in predicting coronary heart disease 2Health News:Informational handout key to giving parents a better understanding of CT radiation risks 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: